These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26818244)

  • 1. Feeling Is Believing: Evaluative Conditioning and the Ethics of Pharmaceutical Advertising.
    Biegler P; Vargas P
    J Bioeth Inq; 2016 Jun; 13(2):271-9. PubMed ID: 26818244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ban the sunset? Nonpropositional content and regulation of pharmaceutical advertising.
    Biegler P; Vargas P
    Am J Bioeth; 2013; 13(5):3-13. PubMed ID: 23557035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filling in the Gaps: Priming and the Ethics of Pharmaceutical Advertising.
    Biegler P
    Kennedy Inst Ethics J; 2015 Jun; 25(2):193-230. PubMed ID: 26144539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can direct-to-consumer advertising of prescription drugs be effectively regulated?
    Lexchin J; Menkes DB
    N Z Med J; 2019 Jun; 132(1496):59-65. PubMed ID: 31170134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
    Kim H
    Int J Health Policy Manag; 2015 Aug; 4(12):813-21. PubMed ID: 26673465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Familiarization and Therapeutic Misconception Via Direct-to-Consumer Information.
    Bélisle-Pipon JC; Williams-Jones B
    J Bioeth Inq; 2015 Jun; 12(2):259-67. PubMed ID: 25963773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct-to-physician and direct-to-consumer advertising: Time to have stringent regulations.
    Kannan S; Gowri S; Tyagi V; Kohli S; Jain R; Kapil P; Bhardwaj A
    Int J Risk Saf Med; 2015; 27(2):77-83. PubMed ID: 26410010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical Test of the Beneficial Consequences of Lifting the Ban on Direct-to-Consumer Advertising for Prescription Drugs in Italy: Experimental Exposure and Questionnaire Study.
    Schulz PJ; Crosignani F; Petrocchi S
    J Med Internet Res; 2023 Jul; 25():e40616. PubMed ID: 37459159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
    Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
    Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Direct-to-Consumer Advertising of Prescription Drugs With Consumer Health-Related Intentions and Beliefs Among Individuals at Risk of Cardiovascular Disease.
    Eisenberg MD; Singh Y; Sood N
    JAMA Health Forum; 2022 Aug; 3(8):e222570. PubMed ID: 36200632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Mackey TK
    Int J Health Policy Manag; 2016 Feb; 5(4):271-4. PubMed ID: 27239871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seeking clarity on help-seeking advertising.
    Amiry EJ; Gilbert J
    Br J Dermatol; 2019 Nov; 181(5):1063-1064. PubMed ID: 31021406
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall.
    O'Donoghue AC; Williams PA; Sullivan HW; Boudewyns V; Squire C; Willoughby JF
    Soc Sci Med; 2014 Nov; 120():1-11. PubMed ID: 25194471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The legal and ethical dimensions of direct-to-consumer advertising of prescription drugs: the case of Pfizer and Lipitor in the United States.
    Koku PS
    Health Mark Q; 2021; 38(1):23-34. PubMed ID: 34219606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Tip of the Iceberg of Misleading Online Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Mintzes B
    Int J Health Policy Manag; 2016 Feb; 5(5):329-31. PubMed ID: 27239883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintaining a Fair Balance? Narrative and Non-Narrative Strategies in Televised Direct-to-Consumer Advertisements for Prescription Drugs Aired in the United States, 2003-2016.
    Liu J; Avery RJ; Kim JJ; Niederdeppe J
    J Health Commun; 2022 Mar; 27(3):183-191. PubMed ID: 35593131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'At-risk' individuals' responses to direct to consumer advertising of prescription drugs: a nationally representative cross-sectional study.
    Khalil Zadeh N; Robertson K; Green JA
    BMJ Open; 2017 Dec; 7(12):e017865. PubMed ID: 29217723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-Regulation in the Pharmaceutical Industry: The Exposure of Children and Adolescents to Erectile Dysfunction Commercials.
    Arnold DG; Oakley JL
    J Health Polit Policy Law; 2019 Oct; 44(5):765-787. PubMed ID: 31199865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions of Direct-to-Consumer Advertising and the Older Adult Population.
    Bailey TA; Fenney M
    Consult Pharm; 2016 Apr; 31(4):215-20. PubMed ID: 27056358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in direct-to-consumer advertising of prescription contraceptives.
    Wu MH; Bartz D; Avorn J; Seeger JD
    Contraception; 2016 May; 93(5):398-405. PubMed ID: 26808088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.